Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Micro Labs Limited is a pharmaceutical company based in India that specializes in the development and manufacturing of a wide range of generic pharmaceutical products. Its offerings include formulations in various therapeutic areas such as cardiovascular, anti-diabetic, and anti-infective, addressing the healthcare needs of patients while ensuring affordability and accessibility.
Micro Labs Limited, is an unlisted public company incorporated on 07 September, 1973. It is classified as a public limited company and is located in , Karnataka. It's authorized share capital is INR 34.00 cr and the total paid-up capital is INR 24.00 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Whole-time Director | Anand Surana
Shareholder
|
00192343 | 16 years |
| Managing Director | Dilip Surana
Shareholder
|
00083030 | 31 years |
| Director | Pramod Kumar Shantilal | 00719828 | 2 years |
| Director | Jain Namrata | 00995817 | 1 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | 3,624.6 | 4,038.4 | 4,801.0 | 5,198.6 | 5,991.1 |
| Operating profit | 785.3 | 1,109.3 | 1,259.7 | 1,258.1 | 1,655.9 |
| Net profit | 557.3 | 1,104.2 | 1,294.4 | 1,069.8 | 1,171.4 |
| Gross margin | 64.2 | 65.7 | 65.7 | 66.5 | 67.3 |
| Operating margin | 21.7 | 27.5 | 26.2 | 24.2 | 27.6 |
| Net margin | 15.2 | 27.0 | 26.6 | 20.4 | 19.3 |
| Networth | 3,524.7 | 4,648.1 | 5,542.6 | 6,599.6 | 7,791.4 |
| Borrowings | 844.5 | 576.3 | 508.9 | 441.4 | 688.7 |
| Assets | 5,210.4 | 5,980.1 | 6,895.4 | 7,902.9 | 9,455.5 |
| Debt to equity | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Current ratio | 2.4 | 3.4 | 3.1 | 3.6 | 3.6 |
| ROE | 15.8 | 23.8 | 23.4 | 16.2 | 15.0 |
| Days payable | 178.0 | 155.0 | 160.0 | 149.0 | 137.0 |
| WC days | 227.0 | 266.0 | 206.0 | 231.0 | 247.0 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 25.2 | 25.2 | 24.4 | 24.4 | 24.0 |
| Reserves | 3,499.5 | 4,622.9 | 5,518.2 | 6,575.3 | 7,767.4 |
| Borrowings + | 844.5 | 576.3 | 508.9 | 441.4 | 688.7 |
| Long term borrowings | 75.3 | 40.3 | 19.9 | - | - |
| Short term borrowings | 769.2 | 536.0 | 489.0 | 441.4 | 688.7 |
| Trade payables + | 633.5 | 586.0 | 720.8 | 711.5 | 738.2 |
| Days payable | 178.0 | 155.0 | 160.0 | 149.0 | 137.0 |
| Other liabilities + | 841.2 | 755.7 | 843.9 | 861.8 | 975.4 |
| Other non-current liabilities | 43.0 | 46.8 | 49.1 | 59.8 | 83.2 |
| Other current liabilities | 164.7 | 122.9 | 73.9 | 90.5 | 154.0 |
| Total liabilities | 5,210.4 | 5,980.1 | 6,895.4 | 7,902.9 | 9,455.5 |
| Fixed Assets + | 952.2 | 971.8 | 1,019.3 | 1,211.1 | 1,462.3 |
| Tangible assets | 778.0 | 786.6 | 909.3 | 977.5 | 1,392.4 |
| CWIP | 169.9 | 182.4 | 107.9 | 224.6 | 62.1 |
| Intangible assets | 4.3 | 2.8 | 2.1 | 9.1 | 7.8 |
| LT loans and advances | 112.9 | 190.1 | 267.3 | 211.9 | 154.7 |
| Other non-current assets | 322.6 | 627.6 | 1,611.5 | 1,945.9 | 2,210.2 |
| Current assets + | 3,822.6 | 4,190.7 | 3,997.4 | 4,533.9 | 5,628.3 |
| Inventories | 735.0 | 855.7 | 917.8 | 954.3 | 1,085.0 |
| Trade receivables | 1,217.5 | 1,187.2 | 1,384.2 | 1,713.6 | 1,930.5 |
| Cash and cash equivalents | 127.7 | 599.5 | 107.1 | 303.6 | 253.2 |
| ST loans and advances | 703.0 | 719.8 | 942.4 | 1,047.1 | 1,752.4 |
| Other current assets | 1,039.5 | 828.6 | 645.9 | 515.4 | 607.1 |
| Total assets | 5,210.4 | 5,980.1 | 6,895.4 | 7,902.9 | 9,455.5 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | 3,624.6 | 4,038.4 | 4,801.0 | 5,198.6 | 5,991.1 |
| Sales growth % | 17.26 | 11.42 | 18.88 | 8.28 | 15.24 |
| Expenses + | 2,999.8 | 3,081.2 | 3,681.1 | 4,106.6 | 4,537.5 |
| Cost of goods | 1,296.3 | 1,383.6 | 1,649.0 | 1,740.4 | 1,959.5 |
| Employee cost | 574.7 | 576.6 | 680.7 | 831.5 | 904.4 |
| Other costs | 968.2 | 968.9 | 1,211.6 | 1,368.5 | 1,471.3 |
| Operating profit + | 785.3 | 1,109.3 | 1,259.7 | 1,258.1 | 1,655.9 |
| Operating margin % | 21.7 | 27.5 | 26.2 | 24.2 | 27.6 |
| Other income | 37.2 | 44.9 | 69.3 | 50.8 | 73.4 |
| Interest | 42.1 | 22.9 | 8.2 | 14.3 | 24.6 |
| Depreciation | 118.4 | 129.1 | 131.6 | 151.8 | 177.7 |
| Exceptional items | - | 345.8 | - | 193.2 | - |
| Profit before tax | 661.9 | 1,348.0 | 1,189.2 | 1,336.0 | 1,527.0 |
| Tax | 104.6 | 243.7 | -105.2 | 266.2 | 355.6 |
| Profit - disc. ops | - | - | - | - | - |
| Net profit | 557.3 | 1,104.2 | 1,294.4 | 1,069.8 | 1,171.4 |
| Net margin % | 15.2 | 27.0 | 26.6 | 20.4 | 19.3 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Net Debt/Equity | 0.2 | 0.0 | 0.1 | 0.0 | 0.1 |
| Total Debt/Assets | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Total Assets/Equity | 1.5 | 1.3 | 1.2 | 1.2 | 1.2 |
| Liquidity + | |||||
| Current Ratio | 2.4 | 3.4 | 3.1 | 3.6 | 3.6 |
| Quick Ratio | 2.0 | 2.7 | 2.4 | 2.9 | 2.9 |
| Interest Coverage | 18.6 | 48.4 | 154.1 | 88.1 | 67.4 |
| Performance | |||||
| Gross Margin | 64.2 | 65.7 | 65.7 | 66.5 | 67.3 |
| Operating Margin | 21.7 | 27.5 | 26.2 | 24.2 | 27.6 |
| Net Margin | 15.2 | 27.0 | 26.6 | 20.4 | 19.3 |
| Return + | |||||
| Return on Equity | 15.8 | 23.8 | 23.4 | 16.2 | 15.0 |
| Pre-tax ROCE | 20.8 | 25.0 | 30.2 | 24.6 | 26.8 |
| Return on Assets | 10.7 | 18.5 | 18.8 | 13.5 | 12.4 |
| Pre-tax ROIC | 15.7 | 21.1 | 19.0 | 16.4 | 18.0 |
| Efficiency + | |||||
| Days Payable | 178.0 | 155.0 | 160.0 | 149.0 | 137.0 |
| Days Inventory | 207.0 | 226.0 | 203.0 | 200.0 | 202.0 |
| Days Receivable | 123.0 | 107.0 | 105.0 | 120.0 | 118.0 |
| Fixed Asset Turnover | 3.8 | 4.2 | 4.7 | 4.3 | 4.1 |
| Total Asset Turnover | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 |
| Working Capital | |||||
| Cash Conversion Cycle | 152.0 | 178.0 | 148.0 | 171.0 | 183.0 |
| Working Capital Days | 227.0 | 266.0 | 206.0 | 231.0 | 247.0 |
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 3
Total Amount : 889.1 cr
Canara Bank
No. of Loans: 1
Total Amount : 250.0 cr
Standard Chartered Bank
No. of Loans: 1
Total Amount : 150.0 cr
IDBI Bank Limited
No. of Loans: 1
Total Amount : 120.0 cr
DBS Bank Limited
No. of Loans: 1
Total Amount : 100.0 cr
CitiBank N.A.
No. of Loans: 2
Total Amount : 80.0 cr
ABN Amro Bank N.V.
No. of Loans: 1
Total Amount : 55.0 cr
State Bank of Mysore
No. of Loans: 4
Total Amount : 9.9 cr
City Union Bank Limited
No. of Loans: 1
Total Amount : 5.0 cr
Central Bank of India
No. of Loans: 3
Total Amount : 0.8 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| BAHL AND COMPANY PRIVATE LIMITED |
Active
|
1.7 Cr | 2 | Karnataka |
| JAIN INTERNATIONAL TRADE ORGANISATION |
Active
|
0.0 | 1 | Maharashtra |
| VNURTURE HEALTHCARE SOFTWARE SOLUTIONS PRIVATE LIMITED |
Active
|
5.2 L | 2 | Karnataka |
| MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED |
Active
|
6.3 Cr | 2 | Karnataka |
| BAHL AND COMPANY PRIVATE LIMITED |
Active
|
3.7 Cr | 2 | Karnataka |
| STERN CHEMPHARM LLP |
Active
|
5.0 Cr | 1 | Karnataka |
| ROLLER FLOUR MILLERS FEDERATION OF INDIA. |
Active
|
0.0 | 1 | Delhi |
| KITHUR CHANNAMMA ROLLER FLOUR MILLS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
10.0 L | 1 | Karnataka |
| PUSKAR INVESTMENTS PRIVATE LIMITED |
Strike Off
|
4.3 L | 1 | Karnataka |
| BRINDAVAN SOFTLAND PRIVATE LIMITED |
Strike Off
|
9.0 L | 1 | Karnataka |
| Kithur Channamma Roller Flour Mills LLP |
Inactive for e-filing
|
10.0 L | 1 | at |
| SUNIL AGRO FOODS LIMITED |
Active
|
3.0 Cr | 1 | Karnataka |
| DNR CORPORATION PRIVATE LIMITED |
Active
|
2.0 L | 1 | Karnataka |
| KARNEET ENTERPRISES(INDIA)PRIVATE LIMITED |
Active
|
1.5 Cr | 1 | Karnataka |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Brown & Burk UK Limited | United Kingdom | - | - |
| Micro Labs GMBH | Germany | - | - |
| Micro Nova Pharmaceuticals Ind Limited | Nigeria | - | - |
| Micro Labs USA Inc | United States | - | - |
| Micro Labs Pty Limited | Australia | - | - |
| Micro Labs Holdings FZLLP | United Arab Emirates | - | - |
| Micro Animals Health Care Pvt Ltd | India | - | - |
| Brown & Burk AB | Sweden | - | - |
| Brown & Burk IR Limited | Ireland | - | - |
| Micro Labs Scientific Office FZ LLC | United Arab Emirates | - | - |
Read more
The incorporation date of MICRO LABS LIMITED is 07 September, 1973
The authorized share capital of MICRO LABS LIMITED is INR ₹ 34.0 Cr.
The paid-up capital of MICRO LABS LIMITED is INR ₹ 24.0 Cr.
The registered address of MICRO LABS LIMITED is 31, RACE COURSE ROAD, Bangalore, Bengaluru, Karnataka, India, 560001 - 560001
The CIN number of MICRO LABS LIMITED is U24232KA1973PLC002401.